Long-Term Efficacy of Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: Data from a Pivotal Phase 3 Clinical Trial. (2018). SKIN The Journal of Cutaneous Medicine, 2(S1), S9. https://doi.org/10.25251/skin.2.supp.9